GEORGES JABALY: Open Payments
NPI 1407827074 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,571 in 115 payments from 25 companies in 2025. Trend: 2023 $2,620 · 2024 $2,705 · 2025 $2,571
Food & beverage: $2,571
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $396 |
| Novo Nordisk Inc | 12 | $294 |
| Boston Scientific Corporation | 2 | $283 |
| HARMONY BIOSCIENCES LLC | 11 | $238 |
| Amgen Inc. | 12 | $180 |
| ABBVIE INC. | 10 | $175 |
| Teva Pharmaceuticals USA, Inc. | 7 | $138 |
| Lundbeck LLC | 3 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $83 |
| GlaxoSmithKline, LLC. | 5 | $80 |
Products named: General - Pain Management, AIRSUPRA, WAKIX, Ozempic, AUSTEDO XR, Wegovy, OTEZLA, BREZTRI.
Industry payments across OH — which companies pay providers there.
